S.Africa’s Aspen Signs Deal Paving Way for J&J COVID Vaccine License

JOHANNESBURG — South Africa’s Aspen Pharmacare took a step towards a licensing deal to package and sell Johnson & Johnson’s COVID-19 vaccine in Africa, announcing on Tuesday it had signed non-binding terms with subsidiaries of the U.S. drugmaker. Read More